IL-10 induces gene expression in macrophages: Partial overlap with IL-5 but not with IL-4 induced genes

Cytokine

Volumn 24, Issue 1-2, 2003, Pages 46-56

  Stumpo, Rita ^a   Kauer, Manfred ^b   Martin, Stephan ^b   Kolb, Hubert ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Cytokines; Inflammation; Molecular biology; Monocytes macrophages

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CELL METABOLISM; CONTROLLED STUDY; EXPRESSED SEQUENCE TAG; GENE EXPRESSION; GENE FUNCTION; GENE SEQUENCE; IMMUNOREGULATION; MACROPHAGE; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; TH1 CELL; TH2 CELL;

EID: 0141928638     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-4666(03)00270-9     Document Type: Article

References (42)

1. Bogdan C., Vodovotz Y., Nathan C. Macrophage deactivation by interleukin 10. J Exp Med. 174:1991;1549-1555.
2. Gazzinelli R.T., Oswald I.P., James S.L., Sher A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J Immunol. 148:1992;1792-1796.
3. Roilides E., Dimitriadou A., Kadiltsoglou I., Sein T., Karpouzas J., Pizzo P.A. et al. IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J Immunol. 158:1997;322-329.
4. Strassmann G., Patil-Koota V., Finkelman F., Fong M., Kambayashi T. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J Exp Med. 180:1994;2365-2370.
5. Fiorentino D.F., Zlotnik A., Vieira P., Mosmann T.R., Howard M., Moore K.W. et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol. 146:1991;3444-3451.
6. D'Andrea A., Aste-Amezaga M., Valiante M.N., Ma X., Kubin M., Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med. 178:1993;1041-1048.
7. Tripp C.S., Wolf S.F., Unanue E.R. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci U S A. 90:1993;3725-3729.
8. Ding L., Linsley P.S., Huang L., Germain R.N., Shevach E.M. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol. 151:1993;1224-1234.
9. Calzada-Wack J.C., Frankenberger M., Ziegler-Heitbrock H.W.L. Interleukin-10 drives human monocytes to CD16 positive macrophages. J Inflamm. 46:1996;78-85.
10. Allavena P., Piemonti L., Longoni D., Bernasconi S., Stoppacciaro A., Ruco L. et al. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur J Immunol. 28:1998;359-369.
11. Diatchenko L., Yun-Fai C.L., Campbell A.P., Chenchik A., Moqadam F., Huang B. et al. Suppression subtractive hybridisation: a method for generating regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci U S A. 93:1996;6025-6030.
12. von Stein O.D., Thies W.-G., Hofmann M. A high throughput screening for rarely transcribed differentially expressed genes. Nucleic Acids Res. 25:1997;2598-2602.
13. Chen W., Syldath U., Bellmann K., Kolb H. Human 60-kD heat shock protein: a danger signal to the innate immune system. J Immunol. 162:1999;3212-3219.
14. Ohashi K., Burkart V., Flohé S., Kolb H. Heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol. 164:2000;558-561.
15. -/- mice: an overview. J Leukoc Biol. 61:1997;389.
16. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci U S A. 99:2002;16899-16903.
17. Kojima H., Gu H., Nomura S., Caldwell C.C., Kobata T., Carmeliet P. et al. Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1-deficient chimeric mice. Proc Natl Acad Sci U S A. 99:2002;2170-2174.
18. Reboul J., Gardiner K., Monneron D., Uze G., Lufalla G. Comparative genomic analysis of the interferon/interleukin-10 receptor gene cluster. Genome Res. 9:(3):1999;242-250.
19. Han C.S., Chen Y., Ezashi T., Roberts M. Antiviral activities of the soluble extracellular domains of type I interferon receptors. Proc Natl Acad Sci U S A. 98:2001;6138-6143.
20. Hardy M.P., Hertzog P.J., Owczarek C.M. Multiple regions within the promoter of the murine Ifnar-2 gene confer basal and inducible expression. Biochem J. 365:2002;355-367.
21. Lehmann J., Seegert D., Strehlow I., Schindler C., Lohmann-Matthes M.L., Decker T. IL-10-induced factors belonging to the p91 family of proteins bind to IFN-gamma-responsive promoter elements. J Immunol. 153:1994;165-172.
22. Lacraz S., Nicod L.P., Chicheportiche R., Welgus H.G., Dayer J.M. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest. 96:1995;2304-2310.
23. Wan J., Sharp S., Poirier G., Wagaman P., Chambers J., Pyati J. et al. Cloning differentially expressed mRNAs. Nat Biotechnol. 14:1996;1685-1691.
24. Segade F., Claudio E., Hurle B., Ramos S., Lazo P.S. Differential regulation of the murine ribosomal protein L26 gene in macrophage activation. Life Sci. 58:1996;277-285.
25. Bogdan C., Paik J., Vodovotz Y., Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J Biol Chem. 267:1992;23301-23308.
26. Oswald I.P., Wynn T.A., Sher A., James S.L. Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis alpha required as a costimulatory factor for interferon gamma-induced activation. Proc Natl Acad Sci U S A. 89:1992;8676-8679.
27. Kim H.S., Armstrong D., Hamilton T.A., Tebo J.M. IL-10 suppresses LPS-induced KC mRNA expression via a translation-dependent decrease in mRNA stability. J Leukoc Biol. 64:1998;33-39.
28. Frigerio J.M., Dusetti N.J., Keim V., Dagorn J.C., Iovanna J.L. Identification of a second rat pancreatitis-associated protein. Messenger RNA cloning, gene structure, and expression during acute pancreatitis. Biochemistry. 32:1993;9236-9241.
29. Ho Y.S., Swenson L., Derewenda U., Serre L., Wei Y., Dauter Z., et al. Brain acetylhydrolase that inactivates platelet-activating factor is a G-protein-like trimer. Nature. 2:(385):1997;89-93.
30. Memon R.A., Fuller J., Moser A.H., Feingold K.R., Grunfeld C. In vivo regulation of plasma platelet-activating factor acetyl hydrolase during the acute phase response. Am J Physiol. 277:(1 Pt 2):1999;R94-R103.
31. Murray J.C., Barnett G., Tas M., Jakobsen A., Brown J., Powe D., et al. Immunohistochemical analysis of endothelial-monocyte-activating polypeptide-II expression in vivo. Am J Pathol. 157:(6):2000;2045-2053.
32. Mueller C.A., Schluesener H.J., Conrad S., Meyermann R., Schwab J.M. Lesional expression of a proinflammatory and antiangiogenic cytokine EMAP II confined to endothelium and microglia/macrophages during secondary damage following experimental traumatic brain injury. J Neuroimmunol. 135:(1-2):2003;1-9.
33. Fleury C., Sanchis D. The mitochondrial uncoupling protein-2: current status. Int J Biochem Cell Biol. 31:1999;1261-1278.
34. Chan C.B., MacDonald P.E., Saleh M.C., Johns D.C., Marban E., Wheeler M.B. Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. Diabetes. 48:1999;1482-1486.
35. Cassell P.G., Neverova M., Janmohamed S., Uwakwe N., Qureshi A., McCarthy M.I., et al. An uncoupling protein 2 gene variant is associated with a raised body mass index but not Type II diabetes. Diabetologia. 42:1999;688-692.
36. Saleh M.C., Wheeler M.B., Chan C.B., Uncoupling protein-2: evidence for its function as a metabolic regulator. Diabetologia. 5:2002;174-187.
37. Blackman J.D., Cabana V.G., Mazzone T. The acute phase response and associated lipoprotein abnormalities accompanying lymphoma. J Intern Med. 233:1993;201-204.
38. Sarraf P., Fredrich R.C., Turner E.M. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anoxia. J Exp Med. 185:1997;171-175.
39. Spiegelman B.M., Hotamisligil G.S. Through thick and thin: wasting, obesity and TNF-α Cell. 73:1993;625-627.
40. Pickup J.C., Matthock M.B., Chusney G.D., Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia. 40:1997;1286-1292.
41. Rutherford M.S., Schook L.B. Differential immunocompetence of macrophages derived using macrophage or granulocyte-macrophage colony-stimulating factor. J Leukoc Biol. 51:1992;69-78.
42. Yang S.-D., Schook L.B., Rutherford M.S. Differential expression of novel genes by bone marrow-derived macrophage populations. Mol Immunol. 32:1995;733-742.